Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Tissue Repair Ltd

TRP.AX ✗ NOT COMPLIANT ☆ Track — members

ASX · Healthcare · Pharmaceuticals ·

Australia Micro Cap Analyst: N/A

Last Close

$0.06

▲ +0.00%

Market Cap $3.63M · Vol 2.60K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$3.63M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

60.87

Momentum

Beta

0.72

vs Market

52W High

$0.34

81.28% below

52W Low

$0.04

56.48% above

Volume

2.60K

Avg 98.72K

P/B

0.80

Price-to-book

ROE

N/A

Return on equity

Free Float

44.74%

Public shares

Shariah Compliance8 STANDARDS

✗ Tissue Repair Ltd (TRP.AX) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TRP.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+2.41%

-22.73%

-32.00%

-52.78%

YTD

-77.92%

-69.09%

-66.22%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$1.99M
Net Income	$-2,788,927.00
Revenue Growth (YoY)	+69.83%
Gross Margin	100.00%
Operating Margin	-147.23%
Net Profit Margin	-140.49%
ROE	N/A
ROA · ROIC	-24.96% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	3.71
P/B	0.80
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	60.46M

Technical Indicators

50-Day SMA	$0.07
200-Day SMA	$0.14
RSI (14)	60.87
Beta	0.72
52-Week High	$0.34
52-Week Low	$0.04

Volume Today	2.60K
Avg Daily Volume (30D)	98.72K
Relative Volume	0.03x
Volatility (10D)	38.65
Volatility (30D)	76.59
Free Float	44.74%

Analyst Consensus

N/A

Current Price $0.06

Mean Target $57.72

52W Low$0.04 52W High$0.34

Current

Target

$0.04 $0.34

Current Analyst target

+96,173.14% upside potential · 0 analysts

Identifiers

ExchangeASX

FIGIBBG012XR9VF4

ISINAU0000180887

CountryAustralia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Tissue Repair Limited is an Australia-based Phase III advanced biotechnology company developing second generation wound healing agents. The Company is focused in entering Phase III clinical trials in chronic wounds for its lead drug candidate Chronic wound treatment (TR-987), with a secondary focus on commercializing Post-procedure cosmeceutical (TR Pro+) a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its other applications of Glucoprime technology include the treatment of burns, an over the counter/pharmacy wound product, new bandage and scaffold products impregnated with Tissue Repair’s active pharmaceutical ingredient, veterinary products, among others.